Cronos CRON
NASDAQ CRON
$3.22 -0.07 (-2.13%)
At close: Aug 20, 2026 · 4:00 PM EDT

Cronos (CRON) Acquisitions (2019)

Cronos (CRON) posted quarterly Acquisitions of $221.3 million for Q4 2019.

Cronos (CRON) Acquisitions (2019) Analysis & Trends

Cronos' Acquisitions history runs 1 years deep, the most recent figure standing at $221.3 million for Q4 2019.

  • In Q4 2019, Acquisitions changed N/A year-over-year to $221.3 million; the TTM figure through Dec 2024 stood at $221.3 million (changed N/A YoY), while the FY2024 annual figure was $6.0 million, changed N/A from the prior year.
  • Acquisitions for Q4 2019 stood at $221.3 million.
  • The five-year high for Acquisitions was $221.3 million in Q4 2019, with the low at $221.3 million in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Cronos 1.20 Bn 407.87 Mn 28.45 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 221.34 Mn